Literature DB >> 22699514

Prevalence of HPV infection and genotypes in women with normal cervical cytology in the state of Paraná, Brazil.

Mariana Clivati da Silva1, Helen Priscila Rodrigues Martins, Jamile Lopes de Souza, Maria Cristina Bronharo Tognim, Terezinha Inez Estivalet Svidzinski, Jorge Juarez Vieira Teixeira, Marcia Edilaine Lopes Consolaro.   

Abstract

OBJECTIVE: We investigated the prevalence of the human Papillomavirus (HPV) and its genotypes in women with normal cervical cytology in the state of Paraná, Brazil, and also epidemiological characteristics.
METHODS: The enrolled patients were seen at six primary health-care units in Paiçandú City, Paraná. Through polymerase chain reaction (PCR) and PCR-RFLP (restriction fragment length polymorphism) techniques, 40 HPV genotypes were found, including 15 high risk, 3 undetermined risk and 22 low risk. Socio-demographic characteristics and sexual behavior were also recorded by interviews based on a structured questionnaire completed at the time of enrollment.
RESULTS: Among 418 patients examined, HPV was detected in 6.7 %, mainly in women aged <25 years. The overall prevalence of high-risk, low-risk and undetermined-risk HPV types was 42.9, 45.7, and 11.7 %, respectively. HPV-16 was the most common type detected (14.3 %), followed by types 66 (11.4 %) and 31 and 70 (8.6 % each). Detection of HPV DNA was positively associated with the number of sexual partners within the previous 12 months (p < 0.031; OR = 5.4; CI = 0.98-29.8).
CONCLUSION: When considering the lack of studies in Paraná on women with normal cytology, the results of this study will improve estimates of HPV DNA populations, and provide baseline values against which the impact of vaccination can be assessed in the future.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22699514     DOI: 10.1007/s00404-012-2399-y

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  9 in total

1.  FOXP3 immunoregulatory gene variants are independent predictors of human papillomavirus infection and cervical cancer precursor lesions.

Authors:  Fernando Cezar-Dos-Santos; Rodolfo Sanches Ferreira; Nádia Calvo Martins Okuyama; Kleber Paiva Trugilo; Michelle Mota Sena; Érica Romão Pereira; Ana Paula Lombardi Pereira; Maria Angelica Ehara Watanabe; Karen Brajão de Oliveira
Journal:  J Cancer Res Clin Oncol       Date:  2019-06-08       Impact factor: 4.553

2.  Prevalence of human papillomavirus infection in Argentinean women attending two different hospitals prior to the implementation of the National Vaccination Program.

Authors:  Diego Chouhy; Rubén Mamprín D'Andrea; Mercedes Iglesias; Analía Messina; Juan J Ivancovich; Belen Cerda; Diana Galimberti; Hebe Bottai; Adriana A Giri
Journal:  J Med Virol       Date:  2013-01-07       Impact factor: 2.327

3.  Prevalence of human papillomavirus infection among women presenting for cervical cancer screening in Chile, 2014-2015.

Authors:  Monserrat Balanda; Andrea Quiero; Nicolás Vergara; Gloria Espinoza; Héctor San Martín; Giovanna Rojas; Eugenio Ramírez
Journal:  Med Microbiol Immunol       Date:  2016-08-18       Impact factor: 3.402

4.  CXCL12/CXCR4 axis gene variants contribute to an increased vulnerability to HPV infection and cervical oncogenesis.

Authors:  Nádia Calvo Martins Okuyama; Fernando Cezar-Dos-Santos; Kleber Paiva Trugilo; Aline Esposito; Roberta Losi Guembarovski; José d'Oliveira Couto-Filho; Maria Angelica Ehara Watanabe; Karen Brajão de Oliveira
Journal:  J Cancer Res Clin Oncol       Date:  2022-01-27       Impact factor: 4.553

5.  Prevalence of HPV and associated factors in a population of women living in southern Brazil.

Authors:  Ana Paula Reolon Bortolli; Indianara Carlotto Treco; Valquíria Kulig Vieira; Claudicéia Risso Pascotto; Lirane Elize Defante Ferreto; Guilherme Welter Wendt; Léia Carolina Lucio
Journal:  Braz J Microbiol       Date:  2022-10-20       Impact factor: 2.214

6.  Prevalence of type-specific HPV among female university students from northern Brazil.

Authors:  Rodrigo Covre Vieira; Jeniffer do Socorro Valente Monteiro; Estéfane Primo Manso; Maria Renata Mendonça Dos Santos; Mihoko Yamamoto Tsutsumi; Edna Aoba Yassui Ishikawa; Stephen Francis Ferrari; Karla Valéria Batista Lima; Maísa Silva de Sousa
Journal:  Infect Agent Cancer       Date:  2015-07-22       Impact factor: 2.965

7.  POP-Brazil study protocol: a nationwide cross-sectional evaluation of the prevalence and genotype distribution of human papillomavirus (HPV) in Brazil.

Authors:  Eliana Marcia Wendland; Juliana Caierão; Carla Domingues; Ana Goretti Kalume Maranhão; Flávia Moreno Alves de Souza; Luciano Serpa Hammes; Maicon Falavigna; Juliana Balbinot Hilgert; Fernando Neves Hugo; Marina Bessel; Luisa Lina Villa; Adele Schwartz Benzaken
Journal:  BMJ Open       Date:  2018-06-07       Impact factor: 2.692

8.  Risk factors for cervical HPV infection and genotypes distribution in HIV-infected South Brazilian women.

Authors:  Sheila C Rocha-Brischiliari; Fabrícia Gimenes; André L P de Abreu; Mary M T Irie; Raquel P Souza; Rosangela G Santana; Angela A F Gravena; Maria D de B Carvalho; Marcia E L Consolaro; Sandra M Pelloso
Journal:  Infect Agent Cancer       Date:  2014-02-11       Impact factor: 2.965

9.  Prevalence of human papillomavirus (HPV) in Brazil: A systematic review and meta-analysis.

Authors:  Verônica Colpani; Frederico Soares Falcetta; Augusto Bacelo Bidinotto; Natália Luiza Kops; Maicon Falavigna; Luciano Serpa Hammes; Adele Schwartz Benzaken; Ana Goretti Kalume Maranhão; Carla Magda Allan S Domingues; Eliana Márcia Wendland
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.